Since 1977, the WHO’s Essential Medicines List has provided an important guide to...
- WHO’s Essential Medicines List: discussing innovation and access
- Can Pharmaoffer become the Amazon of pharma raw materials?
- How automation and man-machine collaboration is reshaping blood storage
- Novartis defends Zolgensma in face of FDA’s data concerns
- Veeva R&D summit: unifying across clinical, regulatory and quality suites
AirBridgeCargo Airlines is Re-Certified for IATA CEIV Pharma
AirBridgeCargo Airlines has successfully gained its IATA CEIV Pharma re-certification following two-day audit procedures for compliance with IATA’s Center of Excellence for Validators in Pharmaceutical Logistics (CEIV Pharma) certification program.
WHO’s Essential Medicines List: discussing innovation and access
Since 1977, the WHO’s Essential Medicines List has provided an important guide to help countries prioritise their own drug procurement. But how does the list operate in the 21st century, and in what ways does it impact the global pharmaceutical industry?
End-to-End Supply Chain Visibility to be Attained Between Kinaxis and Teva
Kinaxis Inc, a leader in empowering people to make confident supply chain decisions, has announced it has been selected by Teva Pharmaceuticals to help Teva connect its data, processes and people into a single platform to transform its global supply chain, improve visibility and operational efficiencies and increase customer satisfaction.
UK’s NAO warns of uncertain medicines supply in no-deal Brexit
A report by the National Audit Office (NAO), UK has warned that a no-deal Brexit still poses a threat to the supply of medicines, indicating the need for more measures to ensure adequate supply.
FDA investigating Zantac for carcinogenic chemicals
Zantac tablets have been found to contain 26,000 times the FDA-approved amount of NDMA (a cancer-causing chemical) that can be safely consumed daily.
Can Pharmaoffer become the Amazon of pharma raw materials?
Disruptions in the supply of the raw materials needed to manufacture medicines are increasingly common. Could the digitisation of the API/excipients marketplace help address the issue? To find out more Abi Millar spoke to Ammar Badwy, co-founder of Dutch start-up Pharmaoffer, which provides a digital platform for drugmakers to connect with qualified material suppliers.
Authorised generics: a poorly known pharma tactic to fend off competition
According to the FDA, there are almost 1,200 authorised generics in the US, and they are currently being approved at a rate of one per week on average.
How automation and man-machine collaboration is reshaping blood storage
Intralogistics industry leader Jungheinrich has helped to build a fully automated blood plasma warehouse for Grifols, a multinational pharmaceutical and chemical manufacturer. Jungheinrich’s UK director of logistics systems Steve Richmond discusses what warehouse automation can do for the pharmaceutical industry.
Novartis defends Zolgensma in face of FDA’s data concerns
The US Food and Drug Administration (FDA) has issued a statement regarding data accuracy issues related with Novartis’ biologic license application (BLA) for gene therapy Zolgensma (onasemnogene abeparvovec-xioi).
Read our magazine
Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.